Skip to main content
Denali Therapeutics Inc. logo

Denali Therapeutics Inc. — Investor Relations & Filings

Ticker · DNLI ISIN · US24823R1059 LEI · 549300ZTQ2HO18L3Q830 US Manufacturing
Open in API
Filings indexed 749 across all filing types
Latest filing 2022-11-29 Director's Dealing
Country US United States of America
Listing US DNLI

About Denali Therapeutics Inc.

https://www.denalitherapeutics.com

Denali Therapeutics Inc. is a biopharmaceutical company dedicated to discovering and developing therapies for neurodegenerative diseases, lysosomal storage disorders, and other serious illnesses. The company's core scientific strategy centers on its proprietary Transport Vehicle™ (TV) platform, which is engineered to transport large therapeutic molecules, such as antibodies and enzymes, across the blood-brain barrier. This technology is designed to overcome a primary obstacle in treating diseases of the central nervous system. Denali's pipeline comprises a portfolio of investigational drug candidates that leverage this platform to target the underlying genetic and biological pathways of complex diseases.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2022-11-29 English
FORM 4
Director's Dealing
2022-11-03 English
10-Q
Interim / Quarterly Report Q3 2022
2022-11-03 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions that the company issued a press release announcing its financial results for the third quarter ended September 30, 2022, and that the press release is attached as an exhibit. The document itself does not contain the financial results but references the press release. The length is 3495 characters, which is relatively short and consistent with an announcement rather than a full report. According to the 'Menu vs Meal' rule, since this document announces the release of financial results and includes a press release, it fits best as an Earnings Release (ER) rather than a full Interim/Quarterly Report (IR) or Annual Report (10-K).
2022-11-03 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement related to a public offering of common stock, including underwriting details and expected proceeds. It also references a press release about the pricing of the offering. There are no financial statements or detailed financial performance data included, only an announcement of a financing event. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities. The document length is 6939 characters, sufficient to provide substantive details about the financing event, not just a brief announcement. Therefore, the correct classification is CAP with high confidence.
2022-10-20 English
424B5
Capital/Financing Update Classification · 95% confidence The document is a 'Prospectus Supplement' filed pursuant to Rule 424(b)(5) under the Securities Act, which is a regulatory filing related to a public offering of common stock. It includes detailed information about the offering, underwriting, risk factors, use of proceeds, and other legal and financial disclosures typical of a prospectus supplement. This type of document is not a financial report, earnings release, or management discussion, but rather a capital markets disclosure related to a financing transaction. Therefore, it fits the category of Capital/Financing Update (CAP). The document length (15,000 characters) and content confirm it is the actual prospectus supplement, not just an announcement of a report, so it is not RPA or RNS. Hence, the correct classification is CAP with high confidence.
2022-10-20 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.